Hirotaka Iwaki
Hirotaka Iwaki
Unknown affiliation
Verified email at
Cited by
Cited by
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
The Lancet Neurology 18 (12), 1091-1102, 2019
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms
C Blauwendraat, K Heilbron, CL Vallerga, S Bandres‐Ciga, R von Coelln, ...
Movement Disorders 34 (6), 866-875, 2019
Genetic modifiers of risk and age at onset in GBA associated Parkinson’s disease and Lewy body dementia
C Blauwendraat, X Reed, L Krohn, K Heilbron, S Bandres-Ciga, M Tan, ...
Brain 143 (1), 234-248, 2020
Genome‐wide association studies of cognitive and motor progression in Parkinson's disease
MMX Tan, MA Lawton, E Jabbari, RH Reynolds, H Iwaki, C Blauwendraat, ...
Movement Disorders 36 (2), 424-433, 2021
Genetic risk of Parkinson disease and progression: an analysis of 13 longitudinal cohorts
H Iwaki, C Blauwendraat, HL Leonard, G Liu, J Maple-Grĝdem, JC Corvol, ...
Neurology: Genetics 5 (4), e348, 2019
Virus exposure and neurodegenerative disease risk across national biobanks
KS Levine, HL Leonard, C Blauwendraat, H Iwaki, N Johnson, ...
Neuron 111 (7), 1086-1093. e2, 2023
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts
H Iwaki, C Blauwendraat, HL Leonard, JJ Kim, G Liu, J Maple‐Grĝdem, ...
Movement Disorders 34 (12), 1839-1850, 2019
System Genomics of Parkinson’s Disease Consortium; International Parkinson’s Disease Genomics Consortium. Identification of novel risk loci, causal insights, and heritable risk …
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
Lancet Neurol 18 (12), 1091-1102, 2019
Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
BioRxiv, 388165, 2019
The Parkinson's disease genome‐wide association study locus browser
FP Grenn, JJ Kim, MB Makarious, H Iwaki, A Illarionova, K Brolin, ...
Movement Disorders 35 (11), 2056-2067, 2020
Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease
S Bandres-Ciga, S Saez-Atienzar, JJ Kim, MB Makarious, F Faghri, ...
Acta neuropathologica 140, 341-358, 2020
The endocytic membrane trafficking pathway plays a major role in the risk of Parkinson's disease
S Bandres‐Ciga, S Saez‐Atienzar, L Bonet‐Ponce, K Billingsley, D Vitale, ...
Movement Disorders 34 (4), 460-468, 2019
Differences in the presentation and progression of Parkinson's disease by sex
H Iwaki, C Blauwendraat, HL Leonard, MB Makarious, JJ Kim, G Liu, ...
Movement Disorders 36 (1), 106-117, 2021
Multi-modality machine learning predicting Parkinson’s disease
MB Makarious, HL Leonard, D Vitale, H Iwaki, L Sargent, A Dadu, I Violich, ...
npj Parkinson's Disease 8 (1), 35, 2022
Accelerating medicines partnership: Parkinson's disease. Genetic resource
H Iwaki, HL Leonard, MB Makarious, M Bookman, B Landin, D Vismer, ...
Movement Disorders 36 (8), 1795-1804, 2021
Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score
H Iwaki, C Blauwendraat, MB Makarious, S Bandrés‐Ciga, HL Leonard, ...
Movement Disorders 35 (5), 774-780, 2020
Parkinson’s disease genetics: identifying novel risk loci, providing causal insights and improving estimates of heritable risk
MA Nalls, C Blauwendraat, CL Vallerga, K Heilbron, S Bandres-Ciga, ...
BioRxiv, 388165, 2018
Differentiation of myocardial ischemia and infarction assessed by dynamic computed tomography perfusion imaging and comparison with cardiac magnetic resonance and single-photon …
Y Tanabe, T Kido, T Uetani, A Kurata, T Kono, A Ogimoto, M Miyagawa, ...
European radiology 26, 3790-3801, 2016
The genetic architecture of Parkinson disease in Spain: characterizing population‐specific risk, differential haplotype structures, and providing etiologic insight
S Bandres‐Ciga, S Ahmed, MS Sabir, C Blauwendraat, ...
Movement Disorders 34 (12), 1851-1863, 2019
GP2: the global Parkinson's genetics program
Global Parkinson's Genetics Program
Movement Disorders 36 (4), 842-851, 2021
The system can't perform the operation now. Try again later.
Articles 1–20